Welcome to our dedicated page for American Oncology Network news (Ticker: AONC), a resource for investors and traders seeking the latest updates and insights on American Oncology Network stock.
American Oncology Network (AON), associated with the symbol AONC, appears frequently in public news releases as a rapidly growing community oncology network. These announcements highlight how AON partners with community-based oncology and hematology practices across multiple states, bringing together physicians and healthcare leaders focused on delivering cancer care close to where patients live and work.
News about American Oncology Network often covers the expansion of its national network, including new partner practices, new clinic locations, and the recruitment of additional board-certified medical oncologists and hematologists. Releases describe practices in states such as Arkansas, Maryland, Texas, and Hawai’i joining or expanding within the network, illustrating AON’s emphasis on community-based care.
Another recurring theme in AON-related news is the development of advanced clinical capabilities and research. Examples include the growth of radiotheranostic and radioligand therapy services at partner practices, the appointment of a radiology medical director and in-house reading radiologist, and the activities of American Oncology Research (AOR), which supports clinical trials in the community setting. AOR’s alliance with Meaningful Insights Biotech Analytics to integrate AI-enhanced data into clinical research within the American Oncology Network is also featured.
In addition, AON news items describe participation in national oncology meetings and research symposia, with multiple abstracts accepted at American Society of Clinical Oncology events. These stories focus on value-based care, cost of care, reimbursement, and social risk factors in oncology. Visitors to the AONC news page can expect coverage of network growth, physician additions, clinic openings, research collaborations, and initiatives aimed at improving access, quality, and equity in community oncology.
RKV Medical Center (AONC) in Muskogee, Oklahoma, joined American Oncology Network on Feb 4, 2026 as AON’s first partner practice in the state.
The partnership aims to expand access to clinical trials, advanced therapies, onsite infusion and radiation services, specialty pharmacy, centralized labs, and continued community-based care under Dr. Ravikumar Vasireddy.
Hematology Oncology of Indiana (AONC) announced that Dr. Amy Braden, DO, a board-certified medical oncologist and hematologist with over 10 years of experience, has joined its physician team and is accepting new patients as of February 3, 2026. Dr. Braden will see patients in Indianapolis, Logansport, and Noblesville.
The practice operates six locations across Indiana and offers specialty infusion, pathology, pharmacy, clinical trials, and BiTE therapy as part of community-based cancer care.
Genesis Cancer and Blood Institute (AONC) announced on Jan 21, 2026 the addition of board-certified endocrinologist Daryl Burrows, MD, and advanced practice nurse Natalie Brown, APRN to its Hot Springs team. The hires expand Genesis to offer onsite endocrinology alongside oncology across 11 Arkansas locations, enabling coordinated endocrine and cancer care at the Genesis Hot Springs—Higdon Ferry clinic.
The staff additions increase local access to diabetes and endocrine services within the community-based cancer practice.
American Oncology Research (AONC) and Meaningful Insights Biotech Analytics (MiBA) announced a strategic alliance on January 15, 2026 to integrate AI-enhanced real-world data into community-based clinical research.
The partnership embeds MiBA’s near-real-time RWD and AI workflows into the American Oncology Network to improve site feasibility, patient matching, enrollment speed, and trial access at the point of care via EMR-integrated insights. The alliance also targets improved trial equity and DAP-aligned enrollment strategies to reduce protocol amendments and support more representative data.
American Oncology Network (NASDAQ:AONC) and Lone Star Oncology announced that Derrick Nguyen, MD, FACP joined Lone Star Oncology's physician team and is accepting new patients as of Jan. 6, 2026. Dr. Nguyen is a Board-certified medical oncologist with over 15 years of practice, trained at the University of Texas Health Science Center and completed residency at the University of New Mexico Health Sciences Center.
Lone Star Oncology opened in June 2023 and joined AON, expanding local access to infusion therapy, centralized lab and pathology, oral oncolytic delivery and financial counseling through the network partnership.
American Oncology Network (NASDAQ:AONC) announced the appointment of Robert J. McDonald, MD, FACNM, as Radiology Medical Director and in-house reading radiologist, effective Dec. 10, 2025. Dr. McDonald will serve as primary reading radiologist for Florida Oncology & Hematology in Naples and Fort Myers and Central Georgia Cancer Care in Macon, provide PET/CT interpretations, perform advanced radiotheranostic therapies at Naples and Fort Myers, and oversee radiology services at supported practices.
He will lead NRC-required clinical preceptorships, refine RLT protocols, and support rollout of newly FDA-approved radiotheranostic therapies as AONC expands RLT capabilities into 2026. Dr. McDonald brings >30 years of diagnostic imaging and radioligand therapy experience.
Hawai’i Cancer Care (AONC partner) opened a new clinic in Kahului, Hawai’i on Dec. 2, 2025 at 17 La’a Street, Unit B, expanding to three statewide locations.
Board-certified oncologists Dr. Melvin P. Palalay and Dr. David J. Tamura and nurse practitioner Judy Ko, RN, MSN, APRN are accepting patients. The clinic offers private exam rooms and an infusion room and will be open on Tuesdays and Wednesdays. New and existing patients can call (808) 727-8341 to schedule appointments.
The practice emphasizes patient-centered, research-based cancer and blood-disorder care, aiming to reduce travel for Maui patients and provide diagnosis, treatment, survivorship, and support locally.
American Oncology Network (NASDAQ:AONC) announced that 15 research abstracts by AON physicians and leaders were accepted for presentation at the ASCO Quality Care Symposium 2025, held Oct. 10-11 in Chicago. Topics span cost of care, the Enhancing Oncology Model (EOM), inflation impacts on reimbursement, biosimilar and Medicare reimbursement policy, episode groupers, clinical adjusters, geography and social deprivation, end-of-life therapy patterns, and outcomes for pembrolizumab weight-based dosing.
The abstracts credit AON leaders and collaborations with Thyme Care and highlight AON’s focus on value-based care, real-world data, and community oncology practice improvements.
American Oncology Network (AONC) and partner practice The Center for Cancer and Blood Disorders announced that board-certified medical oncologist Dr. Chitra Rajagopal has joined the CCBD physician team in Germantown and Bethesda, Maryland.
Dr. Raj trained at Stanley Medical College and completed internal medicine residency at SUNY Downstate and hematology/oncology and bone marrow transplant fellowships at Georgetown Lombardi Cancer Center. She has practiced community-based oncology since 1997 and holds professional society memberships.
Dr. Raj is seeing patients three days weekly in Germantown (primary site) and will expand to four days weekly beginning in January.
American Oncology Network (NASDAQ:AONC) announced that Genesis Cancer and Blood Institute, an AON partner practice, has welcomed Dr. Beau Hilton to its physician care team. Dr. Hilton, who earned his medical degree from Cleveland Clinic Lerner College of Medicine and completed his training at Vanderbilt University Medical Center, joins a team of 10 other medical oncologists.
Genesis Cancer and Blood Institute operates across 11 locations in Arkansas, offering comprehensive cancer services including diagnosis, treatment, clinical trials, and patient support. Dr. Hilton began seeing patients at Genesis Hot Springs clinics on September 1, 2025.